Form 4 for GEHC GE HealthCare
Accepted 2026-05-19 16:05:14 ET · period of report 2026-05-15 · accession 0002027284-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 16:05 | 2026-05-15 | GEHC | Rackliffe Philip | CEO, AIS | A - Grant | $0.00 | +16.5K | 43.2K | +62% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2026-05-15 | A | A | 16,458 | $0.00 | 43,187 | D | — | — | (F1) Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on May 15, 2028, and 50% will vest on May 15, 2029. (F2) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |